Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ...

Pot stocks were among notable underperformers on Thursday, as President Donald Trump signed an executive order to classify marijuana as a less dangerous drug, marking a turning point in the U.S.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Samuel O'Brient Every time Samuel publishes a story, you’ll get an alert straight to your inbox ...

Donald Trump signed an executive order on Dec. 18 to fast-track the Food and Drug Administration's review to reclassify cannabis as a Schedule III substance under the Controlled Substances Act. Pot ...

Cannabis stocks are up on reports that the government could reclassify the drug. Tilray, Cronos, and Canopy Growth all spiked on the news. It's not the first time regulatory hopes have driven big ...